Skip to main content
CDC Website

Health Professionals

Congenital Syphilis and Heat Injuries

This webinar recording explores two critical public health topics: congenital syphilis and heat-related illnesses. Presenters provide an overview of current trends, prevention strategies, and treatment considerations for congenital syphilis, alongside guidance on recognizing, preventing, and managing heat injuries. The session offers practical insights for healthcare providers, public health professionals, and community partners working to address these urgent health concerns.

Getting Displaced With HIV

This webpage outlines the importance of disaster preparedness for people with HIV. Natural disasters—such as hurricanes, tornadoes, tsunamis, and wildfires—can displace anyone, disrupting access to critical HIV medicines and care. It emphasizes the need for individuals with HIV to plan ahead to maintain treatment continuity, protect their health, and reduce the risk of transmission, including steps to connect with new healthcare providers if displaced.

Pharmaceutical Company Patient Assistance Programs and Cost-sharing Assistance Programs: HIV Treatment

This fact sheet discusses that navigating prescription drug access for clients can present many challenges and barriers. NASTAD is committed to developing and maintaining resources highlighting initiatives aiming to maximize affordable access to essential medicines, including programs for uninsured/underinsured individuals and cost-sharing assistance for insured individuals contending with out-of-pocket spending.

Virginia Department of Health

Contact organization for eligibility

Payment and Low Cost Options

  • Fee
  • Insurance Accepted
  • Medicaid Accepted
  • Sliding Scale

  • Chlamydia Test
  • Conventional HIV Test
  • Gonorrhea Test
  • Hepatitis B Test
  • Hepatitis C Test
  • Herpes Test
  • Syphilis Test
  • TB Test

  • Condom Distribution
  • HIV Test Counseling
  • HIV/AIDS Prevention/Education
  • Hepatitis Prevention/Education
  • STI Prevention/Education
  • TB Prevention/Education

  • Adult Hepatitis B Vaccine
  • Doxy PEP
  • Hepatitis A Vaccine
  • Human Papillomavirus Vaccine (HPV)
  • Medication Adherence Education and Counseling
  • STI Treatment
  • TB Treatment

Institute for Family Health

Contact organization for eligibility

Payment and Low Cost Options

  • Insurance Accepted
  • Medicaid Accepted
  • Sliding Scale

  • Chlamydia Test
  • Conventional HIV Test
  • Gonorrhea Test
  • Hepatitis A Test
  • Hepatitis B Test
  • Hepatitis C Test
  • Herpes Test
  • Rapid HIV Test
  • Syphilis Test
  • TB Test

  • Condom Distribution
  • HIV Test Counseling
  • HIV/AIDS Prevention/Education
  • Hepatitis Prevention/Education
  • STI Prevention/Education
  • TB Prevention/Education

  • Adult Hepatitis B Vaccine
  • Doxy PEP
  • Family Planning
  • Hepatitis A Vaccine
  • Hepatitis B Treatment
  • Hepatitis C Treatment
  • Human Papillomavirus Vaccine (HPV)
  • Medication Adherence Education and Counseling
  • Post-Exposure Prophylaxis (PEP)
  • Pre-Exposure Prophylaxis (PrEP)
  • STI Treatment
  • TB Treatment

  • Case Management
  • Drug Purchasing Assistance, including AIDS Drug Purchasing Assistance (ADAP)

Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States

This counseling guide summarizes recommendations from the U.S. Department of Health and Human Services Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission regarding the use of antiretroviral (ARV) drugs during pregnancy or when trying to conceive. Its purpose is to support informed, shared decision-making for individuals living with HIV and their clinicians. Effective antiretroviral therapy (ART) with sustained viral suppression is the cornerstone of maternal health and prevention of perinatal HIV transmission.

Screening for Syphilis Infection During Pregnancy US Preventive Services Task Force Reaffirmation Recommendation Statement

The 2024 US Preventive Services Task Force (USPSTF) Recommendation Statement reaffirms the importance of early screening for syphilis infection in all pregnant individuals to prevent congenital syphilis and associated complications. The report underscores timely testing—including repeat screening in high-risk cases—as a critical measure to safeguard maternal and infant health.